Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Surveillance topic
No spam. Unsubscribe anytime.
Members press for better adverse-event tracking; state says ED visits are tracked
Summary
Council members asked whether the state or CCA is collecting data on negative outcomes and adverse events; CCA staff said they receive complaints and will investigate and BDH said the state tracks cannabis-related emergency department visits and hospitalizations.
At the meeting, members asked about documented negative sequelae from medical cannabis and whether the state has a mechanism to collect adverse-event data.
One member asked, "Data on any of the negative sequelae that have come from medical cannabis being prescribed?" The CCA official replied that the agency does not have a centralized adverse-event reporting system but does receive patient complaints and investigates them; staff said they are working to build better tracking systems and, as the retail market evolves, to collect more intentional adverse-event data.
A representative of the Department of Behavioral Health and Developmental Services told the council that the state does track cannabis-related emergency department visits and cannabis-related inpatient hospitalizations and suggested reviewing that data at a future meeting.
Why it matters: Improving surveillance for adverse outcomes will be important if adult-use sales expand, and members asked staff to return with data and recommended approaches.
